define({"649":{i:0.00131655808185818,u:"../Content/Topics/Model Documentation/Product performance/In Vivo/Human stomach and duodenum/Key equations/Permeation/Permeation.htm",a:"The following rate expression is used to calculate the volume specific rate of permeation: Notation   The surface area available for permeation is calculated from the fluid volume in each intestinal segment. The intestinal segment radius and length is fixed, and it is assumed that the fluid is ...",t:"Permeation"},"650":{i:0.00131655808185818,u:"../Content/Topics/Model Documentation/Product performance/In Vivo/Human stomach and duodenum/Key equations/Permeation/Permeability - Assigned effective permeabliity.htm",a:"Assigned effective permeability The value of   is directly assigned.  This value is not modified by the plicate or villi effects in any segment of the model.    ",t:"Assigned effective permeability"},"651":{i:0.00131655808185818,u:"../Content/Topics/Model Documentation/Product performance/In Vivo/Human stomach and duodenum/Key equations/Permeation/Experimental permeability.htm",a:"The pH partition hypothesis is assumed, i.e. only neutral species permeate via the transcellular route. The in vitro apparent permeability (Papp) is converted to the passive transcellular permeability (Ptrans) using the following equation: Notation   The membrane unstirred water layer permeability ...",t:"Experimental permeability"},"652":{i:0.00131655808185818,u:"../Content/Topics/Model Documentation/Product performance/In Vivo/Human stomach and duodenum/Key equations/Permeation/Permeability - Inactive.htm",a:"Inactive When the inactive option is selected, the value of   is set to zero for all segments.   ",t:"Inactive"},"653":{i:0.00131655808185818,u:"../Content/Topics/Model Documentation/Product performance/In Vivo/Human stomach and duodenum/Key equations/Permeation/Permeability - Sugano 2009.htm",a:"For each permeating species, the effective permeability is calculated as a function of the plicate surface permeability and plicate expansion: Notation   The plicate surface permeability is calculated as: Notation   The membrane unstirred water layer permeability is calculated by the following ...",t:"Sugano, 2009"},"654":{i:0.00131655808185818,u:"../Content/Topics/Model Documentation/Product performance/In Vivo/Human stomach and duodenum/Key equations/Permeation/Permeability - Thelen 2011.htm",a:"Additional terms are added to the expression for the wetted surface area to account for accessibility of the Villi surface, the plicate and the villi.  Notation   The effective permeability is calculated as a function of the membrane affinity and effective molecular weight of the permeants using the ...",t:"Thelen, 2011"},"655":{i:0.00131655808185818,u:"../Content/Topics/Model Documentation/Product performance/In Vivo/Human stomach and duodenum/Key equations/Permeation/Permeability - Assigned epithelial permeability.htm",a:"Assigned epithelial permeability For each permeating species, the effective permeability is calculated using the same equations as the Sugano (2009) model, with the exception that the epithelial permeability is assigned by the user rather than being calculated.",t:"Assigned epithelial permeability"},"656":{i:0.00131655808185818,u:"../Content/Topics/Model Documentation/Product performance/In Vivo/Human stomach and duodenum/Key equations/Dissolution and growth.htm",a:"For each solid phase, a notional liquid surface adjacent to all solid particles is considered. It is assumed that: As the surface has zero volume, there is no accumulation of material.  The dissolution process results in solid species being added to this surface at a rate of   (mol m-2 s-1). ...",t:"Dissolution and growth"},"657":{i:0.00131655808185818,u:"../Content/Topics/Model Documentation/Product performance/In Vivo/Human stomach and duodenum/Key equations/Sherwood number.htm",a:"The Sherwood number represents the ratio of the convective mass transfer to the rate of diffusive mass transport, and is assumed to be 2 in the in vivo models. In the in vitro models, the Sherwood number may be calculated based on the impellor diameter, stirrer speed and impellor power number ...",t:"Sherwood number"},"658":{i:0.00131655808185818,u:"../Content/Topics/Model Documentation/Product performance/In Vivo/Human stomach and duodenum/Key equations/Primary nucleation/Primary nucleation.htm",a:"Primary nucleation Here we define primary nucleation as the formation of crystals from solute entities (molecules or ions) in the solution.  This section contains the following topics:",t:"Primary nucleation"},"659":{i:0.00131655808185818,u:"../Content/Topics/Model Documentation/Product performance/In Vivo/Human stomach and duodenum/Key equations/Primary nucleation/Primary nucleation-Power law kinetics.htm",a:"Empirical power law expressions may be utilised to describe primary nucleation rate kinetics. Two types of power law expressions are available, one where the level of supersaturation is described by the absolute supersaturation, as follows: Notation   The second option available for the power law ...",t:"Power law kinetics"},"660":{i:0.00131655808185818,u:"../Content/Topics/Model Documentation/Product performance/In Vivo/Human stomach and duodenum/Key equations/Primary nucleation/x1.htm",a:"The following rate expression, which can be found in many crystallization textbooks (e.g. Mullin 1  Mullin, J.W. (1993). Crystallization, Butterworth-Heinemann, Boston. ), may be used for describing primary nucleation kinetics: Notation   A further distinction can be made between homogeneous and ...",t:"Classical kinetics (Mullin)"},"661":{i:0.00131655808185818,u:"../Content/Topics/Model Documentation/Product performance/In Vivo/Human stomach and duodenum/Key equations/Modified release.htm",a:"As composite phases disintegrate, the materials contained within them emerge. These phases are referred to as nested phases. The nested phases are born at a rate that is governed by the mass fractions of each nested phase within the composite. The contents of the composite phase are carried from ...",t:"Modified release"},"662":{i:0.00131655808185818,u:"../Content/Topics/Model Documentation/Product performance/In Vivo/Human stomach and duodenum/Key equations/Bile partitioning.htm",a:"Bile partitioning into mixed micelles is considered as additional chemical reaction equilibria, where the equilibrium constant is defined based on an empirical correlation developed from experimental data (Sugano (2012)  1 Sugano, K. (2012) Introduction, in Biopharmaceutics Modeling and Simulations: ...",t:"Bile partitioning"},"663":{i:0.00131655808185818,u:"../Content/Topics/Model Documentation/Product performance/In Vivo/Human stomach and duodenum/Key equations/Diffusivity.htm",a:" Diffusivity of aqueous species The default liquid phase diffusivity of aqueous species is either taken from the literature or calculated by an empirical correlation. It may also be directly assigned by the user. The diffusivity of aqueous neutral and charged active ingredient species is calculated ...",t:"Diffusivity"},"664":{i:0.00131655808185818,u:"../Content/Topics/Model Documentation/Product performance/In Vivo/Human stomach and duodenum/Key equations/Equilibrium reactions.htm",a:"Chemical reaction equilibria are considered in the liquid phase bulk and at all solid-liquid interfaces: Notation   Chemical reaction equilibria are considered for acidic/basic drugs, drug binding to bile micelles and physiological buffers. When specifying dissociation chemical equilibria, the ...",t:"Equilibrium reactions"},"665":{i:0.00131655808185818,u:"../Content/Topics/Model Documentation/Product performance/Phamacokinetics/Pharmacokinetics.htm",a:"Pharmacokinetics The following models are available in this sub-library:",t:"Pharmacokinetics"},"666":{i:0.00131655808185818,u:"../Content/Topics/Model Documentation/Product performance/Phamacokinetics/Plasma concentration monitor/Plasma concentration monitor.htm",a:"The plasma concentration monitor is used to measure the plasma concentration in the compartment pharmacokinetic models and evaluate drug performance via key performance indicators.   Key features:  Plasma concentration  Maximum plasma concentration, Cmax Time of maximum plasma concentration, Tmax ...",t:"Plasma concentration monitor"},"667":{i:0.00131655808185818,u:"../Content/Topics/Model Documentation/Product performance/Phamacokinetics/Single compartment PK/Single compartment PK.htm",a:"The single compartment PK model is used to characterise the pharmacokinetics in the body which it approximates as a single compartment, and describes the plasma concentration of an externally administered drug substance over a period of time.   Key features:  Single compartment  First order or ...",t:"Single compartment PK"},"668":{i:0.00131655808185818,u:"../Content/Topics/Model Documentation/Product performance/Phamacokinetics/Single compartment PK/Assumptions.htm",a:"Assumptions The model is developed under the following assumptions:  The human body can be represented by a single compartment The plasma concentration of an externally administered substance is equal to its concentration in other fluids",t:"Assumptions"},"669":{i:0.00131655808185818,u:"../Content/Topics/Model Documentation/Product performance/Phamacokinetics/Single compartment PK/Key equations.htm",a:"Key equations This section contains the following topics:",t:"Key equations"},"670":{i:0.00131655808185818,u:"../Content/Topics/Model Documentation/Product performance/Phamacokinetics/Single compartment PK/Key equations/Mass balance.htm",a:"Mass balance A basic mass balance is performed over the compartment for the drug substance: Notation",t:"Mass balance"},"671":{i:0.00131655808185818,u:"../Content/Topics/Model Documentation/Product performance/Phamacokinetics/Single compartment PK/Key equations/Elimination rate.htm",a:"The elimination rate is calculated as follows: First order kinetics The first order kinetic model assumes that the elimination rate of a drug in a compartment is directly proportional to the drugs concentration in that compartment: Notation The mass concentration of the drug substance is calculated ...",t:"Elimination rate"},"672":{i:0.00131655808185818,u:"../Content/Topics/Model Documentation/Product performance/Phamacokinetics/Two compartment PK/Two compartment PK.htm",a:"The two compartment PK model is used to characterise the pharmacokinetics in the body which it approximates as two compartments, and describes the plasma concentration of an externally administered drug substance over a period of time.   Key features:  Two compartments  First order or Michaelis ...",t:"Two compartment PK"},"673":{i:0.00131655808185818,u:"../Content/Topics/Model Documentation/Product performance/Phamacokinetics/Two compartment PK/Assumptions.htm",a:"The model is developed under the following assumptions:  The distribution of an externally administered substance in the body can be represented by three compartments. The drug substance is first administered into a central compartment. The drug may be transported to a peripheral compartments once ...",t:"Assumptions"},"674":{i:0.00131655808185818,u:"../Content/Topics/Model Documentation/Product performance/Phamacokinetics/Two compartment PK/Key equations.htm",a:"Key equations This section contains the following topics:",t:"Key equations"},"675":{i:0.00131655808185818,u:"../Content/Topics/Model Documentation/Product performance/Phamacokinetics/Two compartment PK/Key equations/Mass balance.htm",a:"A mass balance is performed over each compartment i for the drug substance: Notation   The inlet mass flow rate of drug substance via permeation or injection of the central compartment is passed from a connected model (either an intravenous injection or a GI tract), and is set to 0 for the ...",t:"Mass balance"},"676":{i:0.00131655808185818,u:"../Content/Topics/Model Documentation/Product performance/Phamacokinetics/Two compartment PK/Key equations/Elimination rate.htm",a:"The elimination rate is calculated as follows: First order kinetics The first order kinetic model assumes that the elimination rate of a drug in a compartment is directly proportional to the drugs concentration in that compartment: Notation The mass concentration of the drug substance is calculated ...",t:"Elimination rate"},"677":{i:0.00131655808185818,u:"../Content/Topics/Model Documentation/Product performance/Phamacokinetics/Three compartment PK/Three compartment PK.htm",a:"The three compartment PK model is used to characterise the pharmacokinetics in the body which it approximates as three compartments, and describes the plasma concentration of an externally administered drug substance over a period of time.   Key features:  Three compartments  First order or ...",t:"Three compartment PK"},"678":{i:0.00131655808185818,u:"../Content/Topics/Model Documentation/Product performance/Phamacokinetics/Three compartment PK/Assumptions.htm",a:"The model is developed under the following assumptions:  The distribution of an externally administered substance in the body can be represented by three compartments The drug substance is first administered into a central compartment The drug may be transported to two peripheral compartments once ...",t:"Assumptions"},"679":{i:0.00131655808185818,u:"../Content/Topics/Model Documentation/Product performance/Phamacokinetics/Three compartment PK/Key equations.htm",a:"Key equations This section contains the following topics:",t:"Key equations"},"680":{i:0.00131655808185818,u:"../Content/Topics/Model Documentation/Product performance/Phamacokinetics/Three compartment PK/Key equations/Mass balance.htm",a:"A mass balance is performed over each compartment i for the drug substance: Notation   The inlet mass flow rate of drug substance via permeation or injection of the central compartment is passed from a connected model (either an intravenous injection or a GI tract), and is set to 0 for the ...",t:"Mass balance"},"681":{i:0.00131655808185818,u:"../Content/Topics/Model Documentation/Product performance/Phamacokinetics/Three compartment PK/Key equations/Elimination rate.htm",a:"The elimination rate is calculated as follows: First order kinetics The first order kinetic model assumes that the elimination rate of a drug in a compartment is directly proportional to the drugs concentration in that compartment: Notation The mass concentration of the drug substance is calculated ...",t:"Elimination rate"},"682":{i:0.00131655808185818,u:"../Content/Topics/Model Documentation/Product performance/Property Tools/Property Tools.htm",a:"Property Tools The following models are available in this sub-library:",t:"Property Tools"},"683":{i:0.00131655808185818,u:"../Content/Topics/Model Documentation/Product performance/Property Tools/Dissolution profile analysis/Dissolution profile analysis.htm",a:"Dissolution profile analysis This model is used to characterise the dissolution profile of the active pharmaceutical ingredient species over time.  ",t:"Dissolution profile analysis"},"684":{i:0.00131655808185818,u:"../Content/Topics/Model Documentation/Product performance/Property Tools/Dissolution profile analysis/Assumptions.htm",a:"The dissolution profile analysis makes the following assumptions:\n Experimental dissolution data should always increase over time. If it decreases at any point, dissolution will be kept constant until the data reaches the same dissolution value where it started decreasing User data is interpolated ...",t:"Assumptions"},"685":{i:0.00131655808185818,u:"../Content/Topics/Model Documentation/Product performance/Property Tools/Dissolution profile analysis/Key equations.htm",a:"Natural cubic splines are a set of polynomials of the form: Notation Defining the distance between two independent points as: And the second derivative   at   as: Applying the conditions for a natural cubic spline, the following coefficients are obtained: Note that the implementation is such that if ...",t:"Key equations"},"686":{i:0.00131655808185818,u:"../Content/Topics/Model Documentation/Product performance/Property Tools/GI speciation analysis/GI speciation analysis.htm",a:"GI speciation analysis This model is used to characterise the molar distribution of active pharmaceutical ingredient species in solution at physiologically relevant pH and bile concentrations.   This section contains the following topics:",t:"GI speciation analysis"},"687":{i:0.00131655808185818,u:"../Content/Topics/Model Documentation/Product performance/Property Tools/GI speciation analysis/Assumptions.htm",a:"Assumptions The model is developed under the following assumptions:  The API species are in equilibrium as determined by the liquid phase reactions.  ",t:"Assumptions"},"688":{i:0.00131655808185818,u:"../Content/Topics/Model Documentation/Product performance/Property Tools/GI speciation analysis/Key equations.htm",a:"Key equations This section contains the following topics:",t:"Key equations"},"689":{i:0.00131655808185818,u:"../Content/Topics/Model Documentation/Product performance/Property Tools/In vitro solubility analysis/In vitro solubility analysis.htm",a:"In vitro solubility analysis This model is used to characterise the solubility of solid forms.   This section contains the following topics:",t:"In vitro solubility analysis"},"690":{i:0.00131655808185818,u:"../Content/Topics/Model Documentation/Product performance/Property Tools/In vitro solubility analysis/Assumptions.htm",a:"The model is developed under the following assumptions:  Liquid phase species are in equilibrium The solvent is pure water In the case of the freeform, the API liquid concentration is equal to its intrinsic solubility In the case of a salt, the ionised API liquid concentration is calculated from its ...",t:"Assumptions"},"691":{i:0.00131655808185818,u:"../Content/Topics/Model Documentation/Product performance/Property Tools/In vitro solubility analysis/Key equations.htm",a:"Key equations This section contains the following topics:",t:"Key equations"},"692":{i:0.00131655808185818,u:"../Content/Topics/Workflow Guides/Workflow Guides.htm",a:"Workflows The documentation is comprised of the following sections:",t:"Workflows"},"693":{i:0.00131655808185818,u:"../Content/Topics/Workflow Guides/Data processing and parameter estimation.htm",a:"Data processing and parameter estimation The documentation is comprised of the following sections:",t:"Data processing and parameter estimation"},"694":{i:0.00131655808185818,u:"../Content/Topics/Workflow Guides/Data processing and parameter estimation/1 Introduction.htm",a:"This user guide provides guidance on how to process experimental or plant data within gPROMS FormulatedProducts and use the data to estimate parameters of the model or flowsheet in gPROMS FormulatedProducts.  A prerequisite to this is a flowsheet configured to your experiment or process. For ...",t:"Introduction"},"695":{i:0.00131655808185818,u:"../Content/Topics/Workflow Guides/Data processing and parameter estimation/2 Importing experimental data.htm",a:"Concept \u003e Performed experiment entity.  gPROMS FormulatedProducts has experiment entities used to represent experiments with their controls and measurements. Each experiment entity must be linked to a Process and are used in parameter estimation.   The Performed experiment entity is used to specify ...",t:"Importing experimental data"},"696":{i:0.00131655808185818,u:"../Content/Topics/Workflow Guides/Data processing and parameter estimation/2.1 General tab.htm",a:"In order to explicitly link an experiment (the Performed experiment entity) to the model/process of the experimental set-up, click on the General tab in the Performed experiment entity editor and then choose the relevant Process from the drop down menu at the top of the window, for example as shown ...",t:"General tab"},"697":{i:0.00131655808185818,u:"../Content/Topics/Workflow Guides/Data processing and parameter estimation/2.2 Controls tab.htm",a:"An experiment control is a variable that is adjusted from one experiment to another (e.g. drying gas temperature) and/or during an experiment (e.g. the flowrate of fluidising gas in a fluidised bed dryer). Experiment controls thus enable the description of the recipes (batch and continuous) and ...",t:"Controls tab"},"698":{i:0.00131655808185818,u:"../Content/Topics/Workflow Guides/Data processing and parameter estimation/2.3 Measurements tab.htm",a:"The measured data of an experiment is entered in the table found on the “Measured data” tab of the Performed experiment entity.  The data table accepts the following information: the name of the measured variable, a name for the sensor used (optional), a description of the measurement variance model ...",t:"Measurements tab"},"699":{i:0.00131655808185818,u:"../Content/Topics/Workflow Guides/Data processing and parameter estimation/3 Simulating an experiment.htm",a:"Always do this before including an experiment in parameter estimation to ensure correct configuration of your flowsheet. To do this, follow the steps below: Right click on the experiment entity. Click on simulate.   gPROMS FormulatedProducts will prompt you for the name of a new Process entity. ...",t:"Simulating an experiment"},"700":{i:0.00131655808185818,u:"../Content/Topics/Workflow Guides/Data processing and parameter estimation/4 Parameter estimation.htm",a:"Concept \u003e Parameter estimation entity. gPROMS FormulatedProducts contains parameter estimation entities that can estimate multiple parameters using measurements from multiple experiments.  Each measurement is associated with a Sensor which is given a variance (through a variance model). Measurements ...",t:"Parameter estimation"},"701":{i:0.00131655808185818,u:"../Content/Topics/Workflow Guides/Data processing and parameter estimation/4.1 Experiments and measurements.htm",a:"To define the experiments that will be used in the Parameter Estimation problem, click on the Experiments and measurements tab and then click the “Add…” button at the top right of the window.  This will open a new window that includes a project tree with all the experiment entities that have been ...",t:"Experiments and measurements"},"702":{i:0.00131655808185818,u:"../Content/Topics/Workflow Guides/Data processing and parameter estimation/4.2 Parameters to be estimated.htm",a:"The Parameters to be estimated are a subset of the ASSIGNed variables in the Process entity, which will change the model predictions if they are adjusted.   Parameter estimation entity - Parameters to be estimated tab.    “Parameters to be estimated”, see Figure above, can be selected by clicking ...",t:"Parameters to be estimated"},"703":{i:0.00131655808185818,u:"../Content/Topics/Workflow Guides/Data processing and parameter estimation/4.3 Solution parameters.htm",a:"Adjusting the output level in the SOLUTIONPARAMETERS section of the Process will enable you to change the amount of information sent to the execution window during the execution of an Estimation activity.  In order to do this it is recommended to follow the points below: Right click on the process ...",t:"Solution parameters"},"704":{i:0.00131655808185818,u:"../Content/Topics/Workflow Guides/Data processing and parameter estimation/5 Analysis of results.htm",a:"Upon completion of a parameter estimation run, a “Results” folder will be created within the parameter estimation case file, as shown below:   Project tree view of a completed parameter estimation case file.   This “Results” folder contains the following files (\u003ccase name\u003e = “small_scale_FBD” in the ...",t:"Analysis of results"},"705":{i:0.0121304479579615,u:"../Content/Topics/Workflow Guides/Data processing and parameter estimation/5.1 Objective function contribution.htm",a:" This section details the contribution of each “Measured Variable” within a given performed experiment entity to the overall objective function value. This section can be utilised to identify possible outliers in the experimental data, by analysing the relative magnitudes of the “Residual Term” for ...",t:"Objective function contribution "},"706":{i:0.00131655808185818,u:"../Content/Topics/Workflow Guides/Data processing and parameter estimation/5.2 Model parameters.htm",a:"This section provides the final optimal values, initial guess, lower and upper bounds for the estimated parameters. The table also describes the confidence intervals, 95% t-values and the standard deviations for each estimated parameter. This section can be utilised to gauge the confidence on the ...",t:"Model parameters"},"707":{i:0.00131655808185818,u:"../Content/Topics/Workflow Guides/Data processing and parameter estimation/5.3 Sensors.htm",a:"The sensors section details the variance models  applied to given measured variables for the parameter estimation. The simultaneous estimation of the best fit variance model parameters is allowed, as well as the model parameters, during a parameter estimation run. If the variance parameters were ...",t:"Sensors"},"708":{i:0.00131655808185818,u:"../Content/Topics/Workflow Guides/Data processing and parameter estimation/5.4 Correlation matrix.htm",a:"Correlation matrix This section provides an indication of correlation between the estimated parameters.  The diagonal values of the table are equal to 1, indicating that each variable is correlated to itself. Values at or near 1 would indicate that certain parameters are strongly correlated.   ",t:"Correlation matrix"},"709":{i:0.00131655808185818,u:"../Content/Topics/Workflow Guides/Data processing and parameter estimation/5.5 Lack of fit test.htm",a:"The lack of fit test table, as shown below, provides a comparison of the weighted residual and chi-squared value (χ2 – Value (95%)). A weighted residual less than the χ2–Value (95%) indicates a good fit between the model and the measured data. It also indicates whether the model sufficiently ...",t:"Lack of fit test"},"710":{i:0.00131655808185818,u:"../Content/Topics/Workflow Guides/Data processing and parameter estimation/5.6 Measurements tab.htm",a:"The measurements tab allows the visual comparison of model predictions with the measured values. The comparison can be viewed using the “View” dropdown selector in three ways, as follows: Measurements Plot – 2-D plot of the measured and predicted values as a function of time, as shown below. Parity ...",t:"Measurements tab"},"711":{i:0.0127302912154125,u:"../Content/Topics/Workflow Guides/Data processing and parameter estimation/6 Appendix A Maximum likelihood.htm",a:"Appendix A – Maximum likelihood objective function\n         Parameter estimation in gPROMS FormulatedProducts is achieved by minimization or optimisation of the overall MAXimum LiKeliHooD (MAXLKHD) objective function. The maximum likelihood objective function can be described as follows:   As ...",t:"Appendix A – Maximum likelihood objective function\n        "},"712":{i:0.00360805958601176,u:"../Content/Topics/Model Documentation/Shared pages/Initial conditions/Particle size distribution - Kumaraswamy.htm",a:"The Kumaraswamy distribution is a double bounded continuous probability distribution, defined on the interval [0,1] and dependent upon the values of two non-negative shape parameters, a and b: In the equations below, parameters to be specified or estimated are printed in blue. Notation The ...",t:"Kumaraswamy distribution"},"713":{i:0.00360805958601176,u:"../Content/Topics/Model Documentation/Shared pages/Initial conditions/Particle size distribution - Weibull or Rosin Rammler.htm",a:"A Weibull/Rosin Rammler distribution is a continuous  probability distribution  and was first applied by Rosin \u0026 Rammler  1 Rosin, P. and Rammler, E., The laws governing the fineness of powder coal, Journal of the Institute of Fuel, 7 (1933), 29-36.  to describe the  particle size distributions  of ...",t:"Weibull/Rosin Rammler distribution"},"714":{i:0.00360805958601176,u:"../Content/Topics/Model Documentation/Shared pages/Initial conditions/Bimodal distribution.htm",a:"Bimodal distribution The bimodal distribution is a  continuous probability distribution with two peaks. Each peak represents a distribution type that is chosen from the probability distributions above. In the equations below, parameters to be specified or estimated are printed in blue. Notation",t:"Bimodal distribution"},"715":{i:0.00360805958601176,u:"../Content/Topics/Model Documentation/Shared pages/Initial conditions/Particle shape factor.htm",a:"For a single particle, the size of which is defined by a length parameter of L, the following equation are applied to calculate its volume (V) and surface area (A).  in which kv and ks are called volumetric shape factor and surface shape factor, respectively.  Notation     For a number of particles ...",t:"Shape factors"},"716":{i:0.00472716497176119,u:"../Content/Topics/Model Documentation/Shared pages/Initial conditions/Material composition.htm",a:"Material Compositions The species compositions in a phase (solid, liquid or vapour phase) can be expressed in a few ways.  Basic definitions   Algebraic relations Notation  ",t:"Material Compositions"},"717":{i:0.00323502445742862,u:"../Content/Topics/Model Documentation/Shared pages/Initial conditions/Material density and void fraction.htm",a:"Inter-particle void is the void between particles. Intra-particle void is the internal void with in particles. Bulk mass density is the mass per particle bulk volume, including inter-particle void and intra-particle void. Particle mass density is the mass per particle volume including only ...",t:"Mass densities and void fractions of particles"},});